The Core Problem in Chronic Fatigue Syndrome Identified? Naviaux’s Metabolomics Study Breaks Fresh Ground
“This work opens a fresh path to both understanding the biology of CFS and, more importantly to patients, a robust, rational way to develop new therapeutics for a disease sorely in need of them.” Robert Naviaux The Dafoe’s looked at each other in astonishment....
The NIH’s Big Change: Is it Coming For Chronic Fatigue Syndrome (ME/CFS)?
VIcky Whittemore and Dr. Koroshetz head the Trans NIH Working group for ME/CFS which is leading the charge to reinvigorate chronic fatigue syndrome (ME/CFS) research at the NIH. As the largest research funder in the world NIH funded research plays a major in the...
Ampligen Takes Big Step Forward – Becomes First Drug Approved Anywhere For Chronic Fatigue Syndrome
Ampligen became the first drug ever approved for use in ME/CFS when ANMAT, Argentine’s FDA, approved the drug for use in severe ME/CFS patients. The approval should provide a clear pathway for Ampligen’s approval elsewhere. The U.S. is the odd man out in...
Iron Man: A Young Person’s POTS ME/CFS Recovery Story
Infection Fells Teenager In August 2014, a formerly very healthy and active Jack Schlanger entered the realm of the chronically ill. The thirteen-year-old’s story began with three days of high fever followed by eight days of lower-grade fever and extreme...StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
